Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Traverse Biotech Logo
Traverse Biotech Growth Score
4
CB Rank
303053
Heat Score
38
Traverse Biotech is an immunotherapy company that focuses on treating patients in the United States.
Founded
obfuscation
PrivateGrant New York, New York, United States1-10 www.traversebiotech.com/
Biotechnology
Overview

Traverse Biotech
Growth Score
4
Heat Score
38

Growth Score4
-6 pts
in past quarter
Heat Score 38
9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Traverse Biotech

CB Rank
303053
Traverse Biotech is an immunotherapy company that focuses on treating patients in the United States.
Founded
obfuscation
PrivateGrant New York, New York, United States1-10 www.traversebiotech.com/
Biotechnology

Funding Rounds

Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Details

Legal Name Traverse Biotech, Inc.
Operating Status Active
Company Type For Profit
About the Company
Traverse Biotech is a privately held biotechnology company that focuses on the late-stage preclinical and early-clinical development of immunotherapy products across multiple platforms.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Bispecific Antibody for Cancer Immunotherapy
A bispecific antibody developed using Genmab's DuoBody® technology, targeting a tumor-associated antigen to direct T cell-mediated cytotoxicity against solid and liquid tumors.
Oral Innate Immunotherapy Stimulant
An oral therapy designed to stimulate the innate immune system by activating monocytic cells using pathogen-associated molecular patterns (PAMPs).

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Traverse Biotech Logo
Grant - Traverse Biotech
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant
obfuscation
Grant - Traverse Biotech Logo
Grant - Traverse Biotech
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant
obfuscation
Grant - Traverse Biotech Logo
Grant - Traverse Biotech
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant
obfuscation
Grant - Traverse Biotech Logo
Grant - Traverse Biotech
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant
obfuscation
Grant - Traverse Biotech Logo
Grant - Traverse Biotech
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant

Funding Rounds

Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Traverse Biotech Logo
Grant - Traverse Biotech
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant
obfuscation
Grant - Traverse Biotech Logo
Grant - Traverse Biotech
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant
obfuscation
Grant - Traverse Biotech Logo
Grant - Traverse Biotech
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant
obfuscation
Grant - Traverse Biotech Logo
Grant - Traverse Biotech
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant
obfuscation
Grant - Traverse Biotech Logo
Grant - Traverse Biotech
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 1
News

News and Press

News•May 26, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

72
20.3%
 in past month

IT Spend

$300.1KThis year, Traverse Biotech is projected to spend $300.1K on IT, according to Aberdeen.

Active Website Tech Count

4Traverse Biotech is actively using 4 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.

Total IP

1Traverse Biotech has 1 registered trademark in the 'Education; entertainment' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Traverse Biotech's headquarters? Traverse Biotech is located in New York, New York, United States.Who invested in Traverse Biotech? Traverse Biotech has 2 investors including National Institute of Allergy and Infectious Diseases and  National Cancer Institute.When was the last funding round for Traverse Biotech? Traverse Biotech closed its last funding round on
obfuscation
from a Grant round.Who are Traverse Biotech's competitors? Alternatives and possible competitors to Traverse Biotech may include Pfizer, AbbVie, and  Roche.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|